VICTORIA, Feb. 20, 2020 /PRNewswire/ - ImmunoPrecise Antibodies Ltd (the "Company"), a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, announces its commitment to the development of innovative vaccines against the new coronavirus originating...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ntibody-program-301008684.html